A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Year to date metric has recorded a gain of 0.28%.However, over the last six months, we can see a weaker performance of 11.14%. Over the last 30 days, the price of TEVA has fallen by 12.45%. And in the last five days, it has surged by 9.99%.
At present, Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has a stock price of $18.06. In the previous session, the stock saw a rise, peaking at $29.0 after an opening price of $18.06. The day’s lowest price was $18.0, and it closed at $17.86.
The market performance of Teva- Pharmaceutical Industries Ltd. ADR’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $22.80 on 12/27/24, while the lowest value for the same duration was $12.47 on 04/10/25.
52-week price history of TEVA Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Teva- Pharmaceutical Industries Ltd. ADR’s current trading price is -20.79% away from its 52-week high, while its distance from the 52-week low is 44.89%. The stock’s price range during this time has been between $12.47 and $22.80. The trading volume for the Healthcare sector company’s shares reached about 11.32 million for the day, which was higher than the average daily volume of 11.26 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has experienced a quarterly rise of 6.61% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 20.71B and boasts a workforce of 36167 employees.
Teva- Pharmaceutical Industries Ltd. ADR: Analysts’ Ratings Unveiled
As of right now, 7 analysts are rating Teva- Pharmaceutical Industries Ltd. ADR as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 16.23, with a change in price of +2.36. Similarly, Teva- Pharmaceutical Industries Ltd. ADR recorded 11,973,771 in trading volume during the last 100 days, posting a change of +15.03%.
TEVA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TEVA stands at 2.57. Similarly, the long-term debt-to-equity ratio is also 2.50.
TEVA Stock Stochastic Average
Today’s raw stochastic average for Teva- Pharmaceutical Industries Ltd. ADR over the last 50 days is 93.17%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 93.37%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 94.82% and 92.60%, respectively.
